Literature DB >> 20434311

Effectiveness of maxillo-mandibular advancement in obstructive sleep apnea patients with and without skeletal anomalies.

P Ronchi1, G Novelli, L Colombo, S Valsecchi, A Oldani, M Zucconi, A Paddeu.   

Abstract

This study evaluates the effectiveness of maxillo-mandibular advancement (MMA) in patients with obstructive sleep apnea syndrome (OSAS), even those without skeletal anomalies, indicating the possibility of extending this procedure to more patients. Two groups with different skeletal patterns were studied pre- and post-surgery. Group 1 (11 patients) had severe or moderate OSAS and maxillo-mandibular hypoplasia and/or mandibular deformities (SNA angle 78 degrees or less or SNA angle>78 degrees but with SNB<65 degrees and severe skeletal class II malocclusion). Group 2 (11 patients) had severe or moderate OSAS without maxillo-mandibular hypoplasia or deformity (SNA angle>80 degrees , dental class I occlusion). Analysis comprised: apnea hypopnea index (AHI), posterior airway space (PAS), SNA and SNB angles, Epworth sleepiness scale (ESS), body mass index (BMI), and a subjective standardized questionnaire about aesthetic appearance. All patients had increased PAS width and complete remission of objective and subjective OSAS symptoms evaluated by AHI and ESS. Results in both groups are comparable. Data were analysed using t-test; p<0.005 was statistically significant. All patients were satisfied with the functional and aesthetic results. MMA is effective in patients with severe or moderate OSAS, even in those without skeletal and/or occlusal anomalies and can be considered in more patients.

Entities:  

Mesh:

Year:  2010        PMID: 20434311     DOI: 10.1016/j.ijom.2010.03.006

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  7 in total

1.  Pycnodysostosis with extreme sleep apnea: a possible alternative to tracheotomy.

Authors:  Giacomo Della Marca; Emanuele Scarano; Chiara Leoni; Serena Dittoni; Anna Losurdo; Elisa Testani; Salvatore Colicchio; Valentina Gnoni; Catello Vollono; Giuseppe Zampino
Journal:  Sleep Breath       Date:  2011-01-14       Impact factor: 2.816

2.  Post-Operative Patients' Satisfaction and Quality of Life Assessment in Adult Patients with Obstructive Sleep Apnea Syndrome (OSAS).

Authors:  Diego Sergio Rossi; Funda Goker; Federico Cullati; Alessandro Baj; Daniele Pignatelli; Aldo Bruno Gianni; Massimo Del Fabbro
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

Review 3.  Maxillomandibular advancement in obstructive sleep apnea syndrome patients: a restrospective study on the sagittal cephalometric variables.

Authors:  Paolo Ronchi; Valentina Cinquini; Alessandro Ambrosoli; Alberto Caprioglio
Journal:  J Oral Maxillofac Res       Date:  2013-07-01

4.  Closure of anterior open bites with mandibular surgery: advantages and disadvantages of this approach.

Authors:  Joseph E Van Sickels; Aaron Wallender
Journal:  Oral Maxillofac Surg       Date:  2012-09-04

5.  Tomographic Analysis of the Impact of Mandibular Advancement Surgery on Increased Airway Volume.

Authors:  Danilo Louzada De Oliveira; Thiago Calcagnotto; Thessio Mina Vago; Hugo Nary Filho; Danilo Pinelli Valarelli; Caio Peres Bellato
Journal:  Ann Maxillofac Surg       Date:  2017 Jul-Dec

6.  Impact of Bimaxillary Advancement Surgery on the Upper Airway and on Obstructive Sleep Apnea Syndrome: a Meta-Analysis.

Authors:  Carolina Rojo-Sanchis; José Manuel Almerich-Silla; Vanessa Paredes-Gallardo; José María Montiel-Company; Carlos Bellot-Arcís
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

7.  Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  David Kent; Jeffrey Stanley; R Nisha Aurora; Corinna G Levine; Daniel J Gottlieb; Matthew D Spann; Carlos A Torre; Katherine Green; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.